Activities per year
Activities
- 46 Oral presentation
- 46 results
Search results
-
シンポジウム「次世代型がん治療法の創製に向けた基礎薬学研究のフロントライン」
Sakurai, H. (Speaker)
2019/03/20 → 2019/03/23Activity: Talk or presentation › Oral presentation
-
Anti-melanoma effect of CDK inhibitor and its combination strategy with BRAF inhibition
Yokoyama, S. (Speaker)
2018/09Activity: Talk or presentation › Oral presentation
-
COPS5はSNAILの脱ユビキチン化を介して、がん転移を制御する
Yokoyama, S. (Speaker)
2018/07Activity: Talk or presentation › Oral presentation
-
Anti-inflammatory effect of Morus alba L. bark to suppresses Toll-like receptor activation in RAW264.7 macrophages
Yokoyama, S. (Speaker)
2017/10Activity: Talk or presentation › Oral presentation
-
オウレンはBAX / BAK の活性化によるアポトーシスを誘導し,悪性黒色腫の成長を阻害する
Yokoyama, S. (Speaker)
2017/09Activity: Talk or presentation › Oral presentation
-
-
Toll 様受容体を介した炎症性シグナルに対する桑白皮の作用
Yokoyama, S. (Speaker)
2017/08Activity: Talk or presentation › Oral presentation
-
マウス花粉症モデルを用いた小青竜湯の薬理作用解析
Yokoyama, S. (Speaker)
2017/08Activity: Talk or presentation › Oral presentation
-
メラノーマにおける脱ユビキチン化酵素PSMD14の細胞増殖および転移に対する効果の検討
Yokoyama, S. (Speaker)
2017/07Activity: Talk or presentation › Oral presentation
-
COP9シグナロソーム5(COPS5)は転写因子SNAILを脱ユビキチン化することにより肺がんの転移を抑制する
Yokoyama, S. (Speaker)
2017/06Activity: Talk or presentation › Oral presentation
-
メラノーマの転移抑制を目指した転写因子SLUG に対する脱ユビキチン化酵素の探索
Yokoyama, S. (Speaker)
2016/09Activity: Talk or presentation › Oral presentation
-
Crucial roles of RSK in cell motility by catalyzing Ser-897 phosphorylation of EphA2
Yokoyama, S. (Speaker)
2016/09Activity: Talk or presentation › Oral presentation
-
Coptidis Rhizoma shows a potential Slug targeted strategy in melanoma metastasis.
Yokoyama, S. (Speaker)
2016/09Activity: Talk or presentation › Oral presentation
-
没薬による免疫チェックポイント分子PD-L1 の発現抑制
Yokoyama, S. (Speaker)
2016/08Activity: Talk or presentation › Oral presentation
-
EphA2チロシンキナーゼ型受容体の非定型的活性化による細胞運動能の制御
Yokoyama, S. (Speaker)
2016/07Activity: Talk or presentation › Oral presentation
-
RSKを介したEphA2 Ser-897リン酸化による細胞運動の制御機構
Yokoyama, S. (Speaker)
2015/10Activity: Talk or presentation › Oral presentation
-
肺がんの転移抑制を目指した転写因子SNAILの脱ユビキチン化酵素の探索
Yokoyama, S. (Speaker)
2015/10Activity: Talk or presentation › Oral presentation
-
細胞内シグナルに対する生薬・漢方方剤の効果
Yokoyama, S. (Speaker)
2015/09Activity: Talk or presentation › Oral presentation
-
-
メラノーマの転移抑制を目指した転写因子SLUGに対する脱ユビキチン化酵素の探索
Yokoyama, S. (Speaker)
2015/07Activity: Talk or presentation › Oral presentation
-
BAX/BAKに着目した悪性黒色腫に対する新規薬剤併用法の探索
Yokoyama, S. (Speaker)
2015/06Activity: Talk or presentation › Oral presentation
-
Comparative study of Kampo medicines on diet-induced mouse obesity model.
Yokoyama, S. (Speaker)
2015/03Activity: Talk or presentation › Oral presentation
-
Effect of Keishibukuryogan on genetic and diet-induced obesity models.
Yokoyama, S. (Speaker)
2014/11Activity: Talk or presentation › Oral presentation
-
Secretory CTGF mediates autonomous MET-like alterations in mesenchymal-transitioned A549 cells.
Yokoyama, S. (Speaker)
2014/09Activity: Talk or presentation › Oral presentation
-
Piperine enhances the efficacy of trail-based therapy for triple-negative breast cancer cells.
Yokoyama, S. (Speaker)
2014/09Activity: Talk or presentation › Oral presentation
-
メラノーマの転移抑制を目指したSLUGに対する脱ユビキチン化酵素の探索
Yokoyama, S. (Speaker)
2014/09Activity: Talk or presentation › Oral presentation
-
腎がん・肺がんの転移抑制活性を有する生薬の探索とその機序解析
Yokoyama, S. (Speaker)
2014/09Activity: Talk or presentation › Oral presentation
-
Sensitization for anti-cancer drug by Saikosaponin B2
Yokoyama, S. (Speaker)
2014/08Activity: Talk or presentation › Oral presentation
-
Identification of novel anti-inflammatory compounds from Morus alba Linne by targeting NF-kB
Yokoyama, S. (Speaker)
2014/08Activity: Talk or presentation › Oral presentation
-
-
肺がんにおけるSNAILに対する脱ユビキチン化酵素の探索
Yokoyama, S. (Speaker)
2014/07Activity: Talk or presentation › Oral presentation
-
-
survivinの抑制がレスベラトロールによる悪性黒色腫のアポトーシスに必須である
Yokoyama, S. (Speaker)
2014/05Activity: Talk or presentation › Oral presentation
-
Resveratrol induces apoptosis in melanoma cells via downregulation of survivin expression.
Yokoyama, S. (Speaker)
2013/10/10 → 2013/10/12Activity: Talk or presentation › Oral presentation
-
Identification of plant extracts sensitizing breast cancer cells to TRAIL.
Yokoyama, S. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
RAC1 inhibitor suppresses gefitinib-resistant NSCLC cell migration.
Yokoyama, S. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
Mesenchymal-transitioned cancer cells instigate surrounding cancer cells to metastasis via secretion of WNT ligands.
Yokoyama, S. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
Resveratrol induces apoptosis in melanoma cells via downregulation of survivin expression.
Yokoyama, S. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
桂皮由来のProcyanidin C1によるTGF-β依存性上皮間葉転換を抑制する機能解析
Yokoyama, S. (Speaker)
2013/08/31 → 2013/09/01Activity: Talk or presentation › Oral presentation
-
Resveratrol induces apoptosis in melanoma cells via downregulation of surviving expression.
Yokoyama, S. (Speaker)
2013/03/21 → 2013/03/22Activity: Talk or presentation › Oral presentation
-
Berberine-induced sensitization of metastatic breast cancer to TRAIL treatment
Yokoyama, S. (Speaker)
2012/09/19 → 2012/09/21Activity: Talk or presentation › Oral presentation
-
間葉転換した上皮系がん細胞に付与されるパラクラインWNTシグナルはEMTの更なる助長を導く
Yokoyama, S. (Speaker)
2012/09/19 → 2012/09/21Activity: Talk or presentation › Oral presentation
-
Mesenchymal-transitioned Epithelial cancer cells instigate EMT via pancreatic WNT signals
Yokoyama, S. (Speaker)
2012/09/02 → 2012/09/05Activity: Talk or presentation › Oral presentation
-
上皮間葉転換を抑制する桂皮の機能解析
Yokoyama, S. (Speaker)
2012/09/01 → 2012/09/02Activity: Talk or presentation › Oral presentation
-
ゲフィチニブによる肺がん転移抑制機構の解 析
Yokoyama, S. (Speaker)
2012/07/12 → 2012/07/14Activity: Talk or presentation › Oral presentation
-
不均一ながん細胞間の相互作用がEMT/METを制御する
Yokoyama, S. (Speaker)
2012/07/12 → 2012/07/14Activity: Talk or presentation › Oral presentation